Kezar Life Sciences Debt to Equity Ratio 2017-2025 | KZR

Current and historical debt to equity ratio values for Kezar Life Sciences (KZR) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Kezar Life Sciences debt/equity for the three months ending September 30, 2025 was 0.02.

Kezar Life Sciences Debt/Equity Ratio Historical Data
Date	Long Term Debt	Shareholder's Equity	Debt to Equity Ratio
2025-09-30	$0.02B	$0.08B	0.18
2025-06-30	$0.02B	$0.09B	0.19
2025-03-31	$0.02B	$0.10B	0.22
2024-12-31	$0.03B	$0.12B	0.24
2024-09-30	$0.03B	$0.13B	0.22
2024-06-30	$0.03B	$0.15B	0.19
2024-03-31	$0.03B	$0.17B	0.18
2023-12-31	$0.03B	$0.19B	0.18
2023-09-30	$0.03B	$0.22B	0.15
2023-06-30	$0.03B	$0.23B	0.13
2023-03-31	$0.03B	$0.25B	0.13
2022-12-31	$0.03B	$0.27B	0.11
2022-09-30	$0.02B	$0.28B	0.08
2022-06-30	$0.02B	$0.30B	0.07
2022-03-31	$0.02B	$0.23B	0.08
2021-12-31	$0.02B	$0.20B	0.11
2021-09-30	$0.01B	$0.12B	0.10
2021-06-30	$0.01B	$0.13B	0.08
2021-03-31	$0.01B	$0.14B	0.08
2020-12-31	$0.01B	$0.14B	0.08
2020-09-30	$0.01B	$0.15B	0.07
2020-06-30	$0.01B	$0.16B	0.06
2020-03-31	$0.01B	$0.12B	0.10
2019-12-31	$0.01B	$0.08B	0.15
2019-09-30	$0.01B	$0.09B	0.13
2019-06-30	$0.01B	$0.10B	0.11
2019-03-31	$0.01B	$0.10B	0.11
2018-12-31	$0.01B	$0.11B	0.05
2018-09-30	$0.01B	$0.11B	0.05
2018-06-30	$0.01B	$0.12B	0.05
2018-03-31	$0.00B	$0.00B	0.00
2017-12-31	$0.00B		0.00
2017-09-30	$0.00B	$0.00B	0.00
2017-06-30	$0.00B	$0.00B	0.00
2016-12-31	$0.00B	$0.01B	0.06

Sector	Industry	Market Cap	Revenue
Medical	Medical - Biomedical and Genetics	$0.045B	$0.007B
Kezar Life Sciences, Inc. is a bio-technology company. It discovers and develops molecule therapeutics and medicines such as protein homeostasis for autoimmune disorders. The company's product pipeline consists of KZR-616 which is in clinical stage. Kezar Life Sciences, Inc. is headquartered in South San Francisco, California.

Stock Name	Country	Market Cap	PE Ratio
AstraZeneca (AZN)	United Kingdom	$288.314B	20.34
Amgen (AMGN)	United States	$185.641B	15.76
Gilead Sciences (GILD)	United States	$168.646B	16.60
Vertex Pharmaceuticals (VRTX)	United States	$118.845B	30.60
Bristol Myers Squibb (BMY)	United States	$111.254B	8.33
GSK (GSK)	United Kingdom	$100.188B	11.09
Regeneron Pharmaceuticals (REGN)	United States	$79.197B	20.54
CSL (CSLLY)	Australia	$60.178B	0.00
Argenex SE (ARGX)	Netherlands	$50.419B	62.29
Alnylam Pharmaceuticals (ALNY)	United States	$47.294B	1556.43
Insmed (INSM)	United States	$33.315B	0.00
BioNTech SE (BNTX)	Germany	$26.117B	0.00
Biogen (BIIB)	United States	$25.173B	10.25
Royalty Pharma (RPRX)	United States	$23.320B	8.94
Illumina (ILMN)	United States	$22.963B	34.47
Revolution Medicines (RVMD)	United States	$22.740B	0.00
Genmab (GMAB)	Denmark	$21.764B	16.37
Incyte (INCY)	United States	$20.023B	19.17
Exact Sciences (EXAS)	United States	$19.512B	538.21
Moderna (MRNA)	United States	$19.033B	0.00
Roivant Sciences (ROIV)	United Kingdom	$15.704B	0.00
Regencell Bioscience Holdings (RGC)	Hong Kong, SAR China	$15.532B	0.00
Ascendis Pharma (ASND)	Denmark	$14.589B	0.00
Guardant Health (GH)	United States	$14.463B	0.00
Swedish Orphan Biovitrum (BIOVF)	Sweden	$13.172B	24.50
Exelixis (EXEL)	United States	$11.869B	19.00
QIAGEN (QGEN)	Netherlands	$11.746B	22.29
Avidity Biosciences (RNA)	United States	$10.939B	0.00
BioMarin Pharmaceutical (BMRN)	United States	$10.799B	19.59
Bio-Techne Corp (TECH)	United States	$10.620B	39.63
Jazz Pharmaceuticals (JAZZ)	Ireland	$10.252B	39.98
Abivax SA (ABVX)	France	$9.580B	0.00
Axsome Therapeutics (AXSM)	United States	$9.375B	0.00
Repligen (RGEN)	United States	$9.138B	97.79
Arrowhead Pharmaceuticals (ARWR)	United States	$9.111B	0.00
Bio-Rad Laboratories (BIO.B)	United States	$8.436B	30.33
Krystal Biotech (KRYS)	United States	$8.164B	42.21
Halozyme Therapeutics (HALO)	United States	$8.140B	13.01
Praxis Precision Medicines (PRAX)	United States	$7.854B	0.00
Cytokinetics (CYTK)	United States	$7.753B	0.00
Nuvalent (NUVL)	United States	$7.739B	0.00
Cidara Therapeutics (CDTX)	United States	$6.960B	0.00
Vaxcyte (PCVX)	United States	$6.903B	0.00
Rhythm Pharmaceuticals (RYTM)	United States	$6.865B	0.00
Merus (MRUS)	Netherlands	$6.826B	0.00
ImmunityBio (IBRX)	United States	$6.353B	0.00
Belite Bio (BLTE)	United States	$6.174B	0.00
PTC Therapeutics (PTCT)	United States	$6.042B	8.21
Alkermes (ALKS)	Ireland	$5.550B	16.32
Structure Therapeutics (GPCR)	United States	$5.483B	0.00
CRISPR Therapeutics AG (CRSP)	Switzerland	$5.291B	0.00
Cogent Biosciences (COGT)	United States	$5.222B	0.00
Protagonist Therapeutics (PTGX)	United States	$5.195B	134.03
Celcuity (CELC)	United States	$5.092B	0.00
Kymera Therapeutics (KYMR)	United States	$5.031B	0.00
TG Therapeutics (TGTX)	United States	$4.953B	11.22
Mirum Pharmaceuticals (MIRM)	United States	$4.846B	0.00
Zealand Pharma (ZLDPF)	Denmark	$4.815B	4.88
Apogee Therapeutics (APGE)	United States	$4.784B	0.00
Immunovant (IMVT)	United States	$4.559B	0.00
ACADIA Pharmaceuticals (ACAD)	United States	$4.541B	38.34
Scholar Rock Holding (SRRK)	United States	$4.518B	0.00
Akero Therapeutics (AKRO)	United States	$4.499B	0.00
Amicus Therapeutics (FOLD)	United States	$4.477B	356.75
CG Oncology (CGON)	United States	$4.341B	0.00
Anbio Biotechnology (NNNN)	Germany	$4.334B	0.00
GRAIL (GRAL)	United States	$4.089B	0.00
ADMA Biologics Inc (ADMA)	United States	$3.982B	28.36
Ligand Pharmaceuticals (LGND)	United States	$3.959B	97.17
Arcellx (ACLX)	United States	$3.915B	0.00
Viking Therapeutics (VKTX)	United States	$3.642B	0.00
Liquidia (LQDA)	United States	$3.531B	0.00
Legend Biotech (LEGN)	United States	$3.511B	0.00
Xenon Pharmaceuticals (XENE)	Canada	$3.227B	0.00
Arcutis Biotherapeutics (ARQT)	United States	$3.209B	0.00
Beam Therapeutics (BEAM)	United States	$3.203B	0.00
Kiniksa Pharmaceuticals (KNSA)	United Kingdom	$3.199B	93.78
Viridian Therapeutics (VRDN)	United States	$3.143B	0.00
Terns Pharmaceuticals (TERN)	United States	$3.092B	0.00
IDEAYA Biosciences (IDYA)	United States	$3.051B	0.00
Vera Therapeutics (VERA)	United States	$3.036B	0.00
Edgewise Therapeutics (EWTX)	United States	$3.029B	0.00
Denali Therapeutics (DNLI)	United States	$2.970B	0.00
Tarsus Pharmaceuticals (TARS)	United States	$2.902B	0.00
Disc Medicine (IRON)	United States	$2.881B	0.00
Adaptive Biotechnologies (ADPT)	United States	$2.832B	0.00
Erasca (ERAS)	United States	$2.826B	0.00
Apellis Pharmaceuticals (APLS)	United States	$2.752B	70.16
HUTCHMED (China) (HCM)	Hong Kong, SAR China	$2.671B	0.00
Travere Therapeutics (TVTX)	United States	$2.634B	0.00
Twist Bioscience (TWST)	United States	$2.631B	0.00
Mineralys Therapeutics (MLYS)	United States	$2.594B	0.00
Telix Pharmaceuticals (TLX)	Australia	$2.578B	0.00
Alumis (ALMS)	United States	$2.560B	0.00
Spyre Therapeutics (SYRE)	United States	$2.486B	0.00
Bavarian Nordic (BVNRY)	Denmark	$2.480B	6.73
Ascentage Pharma Group - (AAPG)	China	$2.471B	0.00
Recursion Pharmaceuticals (RXRX)	United States	$2.459B	0.00
Arcus Biosciences (RCUS)	United States	$2.389B	0.00
Immunome (IMNM)	United States	$2.373B	0.00
Mesoblast (MESO)	Australia	$2.358B	0.00
Ultragenyx Pharmaceutical (RARE)	United States	$2.336B	0.00
WAVE Life Sciences (WVE)	Singapore	$2.252B	0.00
Dianthus Therapeutics (DNTH)	United States	$2.244B	0.00
Sarepta Therapeutics (SRPT)	United States	$2.214B	0.00
Maze Therapeutics (MAZE)	United States	$2.130B	0.00
Harmony Biosciences Holdings (HRMY)	United States	$2.121B	11.58
Zai Lab (ZLAB)	China	$2.052B	0.00
Nuvation Bio (NUVB)	United States	$1.916B	0.00
Vericel (VCEL)	United States	$1.914B	157.71
Sionna Therapeutics (SION)	United States	$1.891B	0.00
Corvus Pharmaceuticals (CRVS)	United States	$1.875B	0.00
ANI Pharmaceuticals (ANIP)	United States	$1.865B	14.46
Dynavax Technologies (DVAX)	United States	$1.821B	53.48
Immunocore Holdings (IMCR)	United Kingdom	$1.774B	0.00
Syndax Pharmaceuticals (SNDX)	United States	$1.760B	0.00
Zymeworks (ZYME)	United States	$1.739B	0.00
Olema Pharmaceuticals (OLMA)	United States	$1.732B	0.00
Celldex Therapeutics (CLDX)	United States	$1.722B	0.00
Definium Therapeutics (DFTX)	United States	$1.714B	0.00
MBX Biosciences (MBX)	United States	$1.700B	0.00
Intellia Therapeutics (NTLA)	United States	$1.695B	0.00
Precigen (PGEN)	United States	$1.684B	0.00
Stoke Therapeutics (STOK)	United States	$1.683B	43.97
MannKind (MNKD)	United States	$1.677B	54.60
Agios Pharmaceuticals (AGIO)	United States	$1.664B	0.00
NeoGenomics (NEO)	United States	$1.657B	0.00
Upstream Bio (UPB)	United States	$1.622B	0.00
Tyra Biosciences (TYRA)	United States	$1.621B	0.00
Rapt Therapeutics (RAPT)	United States	$1.597B	0.00
Certara (CERT)	United States	$1.593B	29.41
Alvotech (ALVO)	Luxembourg	$1.586B	22.87
Tango Therapeutics (TNGX)	United States	$1.577B	0.00
UniQure (QURE)	Netherlands	$1.562B	0.00
Fortrea Holdings (FTRE)	United States	$1.555B	33.00
AtaiBeckley Inc (ATAI)	Netherlands	$1.507B	0.00
NovoCure (NVCR)	Jersey	$1.506B	0.00
Novavax (NVAX)	United States	$1.490B	3.79
Monte Rosa Therapeutics (GLUE)	United States	$1.487B	71.38
Mind Medicine (MindMed) (MNMD)	United States	$1.480B	0.00
Biohaven (BHVN)	United States	$1.430B	0.00
Nurix Therapeutics (NRIX)	United States	$1.427B	0.00
Oculis Holding AG (OCS)	Switzerland	$1.422B	0.00
Pharming Group (PHAR)	Netherlands	$1.382B	0.00
Kodiak Sciences (KOD)	United States	$1.372B	0.00
AnaptysBio (ANAB)	United States	$1.316B	0.00
Oxford BioMedica (OXBDF)	United Kingdom	$1.309B	0.00
Sana Biotechnology (SANA)	United States	$1.287B	0.00
Rapport Therapeutics (RAPP)	United States	$1.284B	0.00
Trevi Therapeutics (TRVI)	United States	$1.281B	0.00
AbCellera Biologics (ABCL)	Canada	$1.269B	0.00
EyePoint (EYPT)	United States	$1.257B	0.00
Castle Biosciences (CSTL)	United States	$1.233B	168.96
Day One Biopharmaceuticals (DAWN)	United States	$1.227B	0.00
Immatics (IMTX)	Germany	$1.205B	0.00
Oric Pharmaceuticals (ORIC)	United States	$1.168B	0.00
Septerna (SEPN)	United States	$1.154B	0.00
Inhibrx Biosciences (INBX)	United States	$1.086B	0.00
Zenas BioPharma (ZBIO)	United States	$1.078B	0.00
Vir Biotechnology (VIR)	United States	$1.052B	0.00
Compass Therapeutics (CMPX)	United States	$1.049B	0.00
Iovance Biotherapeutics (IOVA)	United States	$1.048B	0.00
Inventiva S.A (IVA)	France	$1.044B	0.00
MoonLake Immunotherapeutics (MLTX)	Switzerland	$1.019B	0.00
Nanobiotix S.A - (NBTX)	France	$1.014B	0.00
Palvella Therapeutics (PVLA)	United States	$1.010B	0.00
BridgeBio Oncology Therapeutics (BBOT)	United States	$1.009B	0.00
Ventyx Biosciences (VTYX)	United States	$1.001B	0.00
DBV Technologies S.A (DBVT)	France	$0.985B	0.00
Phathom Pharmaceuticals (PHAT)	United States	$0.964B	0.00
ArriVent BioPharma (AVBP)	United States	$0.958B	0.00
CytomX Therapeutics (CTMX)	United States	$0.939B	13.85
Urogen Pharma (URGN)	United States	$0.936B	0.00
CureVac (CVAC)	Germany	$0.927B	0.00
Bicara Therapeutics (BCAX)	United States	$0.917B	0.00
Basilea Pharmaceutica AG (BPMUF)	Switzerland	$0.908B	0.00
Janux Therapeutics (JANX)	United States	$0.891B	0.00
Pacira BioSciences (PCRX)	United States	$0.889B	10.18
Geron (GERN)	United States	$0.881B	0.00
YD Bio (YDES)		$0.872B	0.00
GH Research (GHRS)	Ireland	$0.870B	0.00
Bright Minds Biosciences (DRUG)	United States	$0.847B	0.00
Arvinas (ARVN)	United States	$0.828B	0.00
MapLight Therapeutics (MPLT)	United States	$0.816B	0.00
EnGene Holdings (ENGN)	Canada	$0.815B	0.00
Annexon (ANNX)	United States	$0.811B	0.00
Jade Biosciences (JBIO)	United States	$0.804B	0.00
Prime Medicine (PRME)	United States	$0.800B	0.00
Arbutus Biopharma (ABUS)	United States	$0.781B	0.00
MiMedx (MDXG)	United States	$0.779B	13.84
Gyre Therapeutics (GYRE)	United States	$0.756B	98.12
Kura Oncology (KURA)	United States	$0.751B	0.00
Cullinan Therapeutics (CGEM)	United States	$0.738B	0.00
Astria Therapeutics (ATXS)	United States	$0.718B	0.00
REGENXBIO (RGNX)	United States	$0.698B	0.00
BioAge Labs (BIOA)	United States	$0.674B	0.00
Cytek Biosciences (CTKB)	United States	$0.674B	0.00
MeiraGTx Holdings (MGTX)	United States	$0.652B	0.00
Sinovac Biotech (SVA)	China	$0.645B	0.00
LENZ Therapeutics (LENZ)	United States	$0.640B	0.00
Emergent Biosolutions (EBS)	United States	$0.628B	6.04
Gossamer Bio (GOSS)	United States	$0.625B	0.00
Lexicon Pharmaceuticals (LXRX)	United States	$0.618B	0.00
Ginkgo Bioworks Holdings (DNA)	United States	$0.607B	0.00
SELLAS Life Sciences (SLS)	United States	$0.607B	0.00
LB Pharmaceuticals Inc (LBRX)	United States	$0.605B	0.00
Replimune (REPL)	United States	$0.605B	0.00
Evommune (EVMN)	United States	$0.595B	0.00
Keros Therapeutics (KROS)	United States	$0.585B	12.47
Fulcrum Therapeutics (FULC)	United States	$0.582B	0.00
Design Therapeutics (DSGN)	United States	$0.580B	0.00
CorMedix Inc (CRMD)	United States	$0.573B	5.31
Myriad Genetics (MYGN)	United States	$0.547B	0.00
Prothena (PRTA)	Ireland	$0.538B	0.00
Ocugen (OCGN)	United States	$0.518B	0.00
Alto Neuroscience (ANRO)	United States	$0.516B	0.00
Solid Biosciences (SLDB)	United States	$0.514B	0.00
Monopar Therapeutics (MNPR)	United States	$0.501B	0.00
Invivyd (IVVD)	United States	$0.492B	0.00
Bicycle Therapeutics (BCYC)	United Kingdom	$0.482B	0.00
Niagen Bioscience (NAGE)	United States	$0.480B	37.56
Vanda Pharmaceuticals (VNDA)	United States	$0.473B	0.00
Northwest Biotherapeutics (NWBO)	United States	$0.472B	0.00
Anavex Life Sciences (AVXL)	United States	$0.470B	0.00
Prima BioMed (IMMP)	Australia	$0.467B	0.00
Kamada (KMDA)	Israel	$0.455B	22.00
NovaBridge Biosciences (NBP)	United States	$0.448B	0.00
PureTech Health (PRTC)	United States	$0.448B	0.00
ADC Therapeutics SA (ADCT)	Switzerland	$0.447B	0.00
DiaMedica Therapeutics (DMAC)	United States	$0.443B	0.00
Absci (ABSI)	United States	$0.438B	0.00
Entrada Therapeutics (TRDA)	United States	$0.437B	0.00
Kyverna Therapeutics (KYTX)	United States	$0.427B	0.00
Verastem (VSTM)	United States	$0.426B	0.00
Benitec Biopharma (BNTC)	United States	$0.423B	0.00
Zura Bio (ZURA)	United States	$0.414B	0.00
Rocket Pharmaceuticals (RCKT)	United States	$0.403B	0.00
Eton Pharmaceuticals (ETON)	United States	$0.402B	0.00
Forte Biosciences (FBRX)	United States	$0.400B	0.00
Autolus Therapeutics (AUTL)	United Kingdom	$0.389B	0.00
Allogene Therapeutics (ALLO)	United States	$0.387B	0.00
Contineum Therapeutics (CTNM)	United States	$0.379B	0.00
Tectonic Therapeutic (TECX)	United States	$0.377B	0.00
Enanta Pharmaceuticals (ENTA)	United States	$0.376B	0.00
PepGen (PEPG)	United States	$0.375B	0.00
AC Immune (ACIU)	Switzerland	$0.372B	0.00
BGM Group (BGM)	China	$0.362B	0.00
Aura Biosciences (AURA)	United States	$0.361B	0.00
Greenwich LifeSciences (GLSI)	United States	$0.353B	0.00
Immuneering (IMRX)	United States	$0.346B	0.00
Neumora Therapeutics (NMRA)	United States	$0.344B	0.00
Climb Bio (CLYM)	United States	$0.342B	0.00
Candel Therapeutics (CADL)	United States	$0.340B	0.00
Amarin (AMRN)	Ireland	$0.338B	0.00
Foghorn Therapeutics (FHTX)	United States	$0.333B	0.00
XOMA Royalty (XOMA)	United States	$0.331B	0.00
Aardvark Therapeutics (AARD)	United States	$0.327B	0.00
Rezolute (RZLT)	United States	$0.326B	0.00
Eupraxia Pharmaceuticals (EPRX)	Canada	$0.324B	0.00
X4 Pharmaceuticals (XFOR)	United States	$0.324B	0.00
Puma Biotechnology (PBYI)	United States	$0.324B	8.68
GENFIT S.A (GNFTY)	France	$0.323B	0.00
Atea Pharmaceuticals (AVIR)	United States	$0.322B	0.00
Lifecore Biomedical (LFCR)	United States	$0.321B	0.00
Prenetics Global (PRE)	Hong Kong, SAR China	$0.310B	0.00
Cabaletta Bio (CABA)	United States	$0.306B	0.00
Immix Biopharma (IMMX)	United States	$0.285B	0.00
Palisade Bio (PALI)	United States	$0.285B	0.00
Neurogene (NGNE)	United States	$0.284B	0.00
Abeona Therapeutics (ABEO)	United States	$0.280B	4.57
Shattuck Labs (STTK)	United States	$0.263B	0.00
Adherex Technologies (FENC)	United States	$0.262B	0.00
Nautilus Biotechnology (NAUT)	United States	$0.261B	0.00
Coherus Oncology (CHRS)	United States	$0.249B	0.00
Adocia (ADOCY)	France	$0.231B	0.00
Jyong Biotech (MENS)	Taiwan	$0.230B	0.00
Orchestra BioMed Holdings (OBIO)	United States	$0.228B	0.00
Voyager Therapeutics (VYGR)	United States	$0.222B	0.00
Nuvectis Pharma (NVCT)	United States	$0.220B	0.00
Arcturus Therapeutics Holdings (ARCT)	United States	$0.214B	0.00
Zentalis Pharmaceuticals (ZNTL)	United States	$0.212B	0.00
Alector (ALEC)	United States	$0.212B	0.00
Editas Medicine (EDIT)	United States	$0.211B	0.00
C4 Therapeutics (CCCC)	United States	$0.208B	0.00
Sagimet Biosciences (SGMT)	United States	$0.200B	0.00
Cartesian Therapeutics (RNAC)	United States	$0.199B	0.00
Humacyte (HUMA)	United States	$0.197B	0.00
Cardiff Oncology (CRDF)	United States	$0.195B	0.00
Tiziana Life Sciences (TLSA)	United Kingdom	$0.194B	0.00
SAB Biotherapeutics (SABS)	United States	$0.192B	0.00
CAMP4 Therapeutics (CAMP)	United States	$0.188B	0.00
ProQR Therapeutics (PRQR)	Netherlands	$0.184B	0.00
Kalaris Therapeutics (KLRS)	United States	$0.183B	0.00
Crescent Biopharma (CBIO)	United States	$0.178B	0.00
Alpha Teknova (TKNO)	United States	$0.178B	0.00
Nkarta (NKTX)	United States	$0.177B	0.00
Opus Genetics (IRD)	United States	$0.177B	0.00
Vor Biopharma (VOR)		$0.173B	0.00
Quince Therapeutics (QNCX)	United States	$0.172B	0.00
Rani Therapeutics Holdings (RANI)	United States	$0.169B	0.00
Milestone Pharmaceuticals (MIST)	Canada	$0.169B	0.00
Innate Pharma S.A (IPHA)	France	$0.168B	0.00
Molecular Partners AG (MOLN)	Switzerland	$0.165B	0.00
Alps Group (ALPS)	United States	$0.161B	2.94
Codexis (CDXS)	United States	$0.152B	0.00
Black Diamond Therapeutics (BDTX)	United States	$0.149B	7.25
Mersana Therapeutics (MRSN)	United States	$0.145B	0.00
Turn Therapeutics (TTRX)	United States	$0.143B	0.00
Caribou Biosciences (CRBU)	United States	$0.143B	0.00
Connect Biopharma Holdings (CNTB)	United States	$0.142B	0.00
Elicio Therapeutics (ELTX)	United States	$0.142B	0.00
Fate Therapeutics (FATE)	United States	$0.140B	0.00
Spero Therapeutics (SPRO)	United States	$0.137B	0.00
Seres Therapeutics (MCRB)	United States	$0.136B	0.00
VTv Therapeutics (VTVT)	United States	$0.134B	0.00
Anika Therapeutics (ANIK)	United States	$0.134B	0.00
Oncolytics Biotech (ONCY)	Canada	$0.132B	0.00
Alpha Cognition (ACOG)	Canada	$0.129B	0.00
Eledon Pharmaceuticals (ELDN)	United States	$0.128B	0.00
Sutro Biopharma (STRO)	United States	$0.128B	0.00
Sangamo Therapeutics (SGMO)	United States	$0.128B	0.00
Whitehawk Therapeutics (WHWK)	United States	$0.127B	0.00
Cognition Therapeutics (CGTX)	United States	$0.126B	0.00
MaxCyte (MXCT)	United States	$0.124B	0.00
Actuate Therapeutics (ACTU)	United States	$0.123B	0.00
Tenaya Therapeutics (TNYA)	United States	$0.122B	0.00
Ovid Therapeutics (OVID)	United States	$0.120B	0.00
BioStem Technologies (BSEM)		$0.120B	8.41
Acumen Pharmaceuticals (ABOS)	United States	$0.120B	0.00
Adagene (ADAG)	China	$0.117B	0.00
Artiva Biotherapeutics (ARTV)	United States	$0.117B	0.00
Repare Therapeutics (RPTX)	Canada	$0.113B	0.00
Tharimmune (THAR)	United States	$0.112B	0.00
Agenus (AGEN)	United States	$0.110B	0.00
Genelux (GNLX)	United States	$0.109B	0.00
ANIXA BIOSCIENCES INC (ANIX)	United States	$0.109B	0.00
Seer (SEER)	United States	$0.107B	0.00
Fortress Biotech (FBIO)	United States	$0.106B	0.00
Inovio Pharmaceuticals (INO)	United States	$0.101B	0.00
EXoZymes (EXOZ)	United States	$0.100B	0.00
Coya Therapeutics (COYA)	United States	$0.099B	0.00
Adlai Nortye (ANL)	Cayman Islands	$0.097B	0.00
Starpharma Holdings (SPHRY)	Australia	$0.097B	0.00
Chrome Holding (MEHCQ)	United States	$0.096B	0.00
Adverum Biotechnologies (ADVM)	United States	$0.096B	0.00
Citius Oncology (CTOR)	United States	$0.096B	0.00
Biomea Fusion (BMEA)	United States	$0.095B	0.00
Scilex Holding (SCLX)	United States	$0.093B	0.00
BioHarvest Sciences (BHST)	Canada	$0.092B	0.00
Tenax Therapeutics (TENX)	United States	$0.092B	0.00
MediciNova (MNOV)	United States	$0.091B	0.00
Spruce Biosciences (SPRB)	United States	$0.087B	0.00
Mereo BioPharma Group - (MREO)	United Kingdom	$0.084B	0.00
OKYO Pharma (OKYO)		$0.084B	0.00
Immunic (IMUX)	United States	$0.083B	0.00
XBiotech (XBIT)	United States	$0.082B	0.00
Adicet Bio (ACET)	United States	$0.081B	0.00
ImageneBio (IMA)	United States	$0.081B	0.00
Pliant Therapeutics (PLRX)	United States	$0.080B	0.00
Annovis Bio (ANVS)	United States	$0.080B	0.00
Equillium (EQ)	United States	$0.077B	0.00
ALX Oncology Holdings (ALXO)	United States	$0.076B	0.00
CalciMedica (CALC)	United States	$0.076B	0.00
Coeptis Therapeutics Holdings (COEP)	United States	$0.075B	0.00
Entera Bio (ENTX)	Israel	$0.073B	0.00
ATyr Pharma (ATYR)	United States	$0.071B	0.00
Tevogen Bio Holdings (TVGN)	United States	$0.070B	0.00
InflaRx (IFRX)	Germany	$0.068B	0.00
BeyondSpring (BYSI)	United States	$0.065B	0.00
TScan Therapeutics (TCRX)	United States	$0.065B	0.00
MIRA Pharmaceuticals (MIRA)	United States	$0.060B	0.00
Grace Therapeutics (GRCE)	United States	$0.059B	0.00
MiNK Therapeutics (INKT)	United States	$0.059B	0.00
Radiopharm Theranostics - (RADX)	Australia	$0.058B	0.00
CervoMed (CRVO)	United States	$0.058B	0.00
Clene (CLNN)	United States	$0.058B	0.00
Precision BioSciences (DTIL)	United States	$0.056B	0.00
IBio (IBIO)	United States	$0.051B	0.00
ABVC BioPharma (ABVC)	United States	$0.050B	0.00
Aligos Therapeutics (ALGS)	United States	$0.050B	0.00
Zhengye Biotechnology Holding (ZYBT)	China	$0.049B	0.00
Instil Bio (TIL)	United States	$0.048B	0.00
Q32 Bio (QTTB)	United States	$0.048B	0.00
PDS Biotechnology (PDSB)	United States	$0.047B	0.00
INmune Bio (INMB)	United States	$0.045B	0.00
Tvardi Therapeutics (TVRD)	United States	$0.044B	0.00
Anebulo Pharmaceuticals (ANEB)	United States	$0.044B	0.00
Jasper Therapeutics (JSPR)	United States	$0.044B	0.00
NextCure (NXTC)	United States	$0.042B	0.00
Galecto (GLTO)	Denmark	$0.041B	0.00
Elutia (ELUT)	United States	$0.041B	0.00
Passage Bio (PASG)	United States	$0.040B	0.00
BioXcel Therapeutics (BTAI)	United States	$0.040B	0.00
OnKure Therapeutics (OKUR)	United States	$0.040B	0.00
TELA Bio (TELA)	United States	$0.039B	0.00
Exicure (XCUR)	United States	$0.039B	0.00
Lantern Pharma (LTRN)	United States	$0.039B	0.00
Generation Bio (GBIO)	United States	$0.038B	0.00
Estrella Immunopharma (ESLA)	United States	$0.038B	0.00
Atara Biotherapeutics (ATRA)	United States	$0.038B	2.39
Celularity (CELU)	United States	$0.037B	0.00
Femasys (FEMY)	United States	$0.037B	0.00
RenovoRx (RNXT)	United States	$0.037B	0.00
Cingulate (CING)	United States	$0.036B	0.00
Lisata Therapeutics (LSTA)	United States	$0.036B	0.00
Rein Therapeutics (RNTX)	United States	$0.036B	0.00
Kyntra Bio Inc (KYNB)	United States	$0.035B	0.00
Medicus Pharma (MDCX)	United States	$0.034B	0.00
TuHURA Biosciences (HURA)	United States	$0.034B	0.00
Pluri (PLUR)	Israel	$0.033B	0.00
Xilio Therapeutics (XLO)	United States	$0.033B	0.00
Werewolf Therapeutics (HOWL)	United States	$0.033B	0.00
Dyadic (DYAI)	United States	$0.033B	0.00
Skye Bioscience (SKYE)	United States	$0.032B	0.00
Oncobiologics (OTLK)	United States	$0.032B	0.00
AN2 Therapeutics (ANTX)	United States	$0.032B	0.00
Alterity Therapeutics - (ATHE)	Australia	$0.031B	0.00
Cue Biopharma (CUE)	United States	$0.030B	0.00
Barinthus Biotherapeutics (BRNS)	United States	$0.029B	0.00
Senti Biosciences (SNTI)	United States	$0.028B	0.00
Rallybio (RLYB)	United States	$0.028B	0.00
Boundless Bio (BOLD)	United States	$0.028B	0.00
Dare Bioscience (DARE)	United States	$0.028B	0.00
Aytu BioPharma (AYTU)	United States	$0.028B	0.00
Athira Pharma (ATHA)	United States	$0.027B	0.00
FibroBiologics (FBLG)	United States	$0.027B	0.00
IO Biotech (IOBT)	Denmark	$0.026B	0.00
VistaGen Therapeutics (VTGN)	United States	$0.025B	0.00
Genenta Science S.p.A (GNTA)	Italy	$0.025B	0.00
Lixte Biotechnology Holdings (LIXT)	United States	$0.025B	0.00
Hyperion DeFi (HYPD)	United States	$0.025B	0.00
CollPlant Biotechnologies (CLGN)	Israel	$0.024B	0.00
Intensity Therapeutics (INTS)	United States	$0.024B	0.00
Quantum Biopharma (QNTM)	Canada	$0.024B	0.00
LeonaBio (LONA)	United States	$0.023B	0.00
Neuphoria Therapeutics (NEUP)	United States	$0.023B	0.00
Lexaria Bioscience (LEXX)	Canada	$0.021B	0.00
Black Titan (BTTC)	United States	$0.021B	0.00
Pasithea Therapeutics (KTTA)	United States	$0.021B	0.00
BioAtla (BCAB)	United States	$0.021B	0.00
Promis Neurosciences (PMN)	Canada	$0.020B	0.00
Apollomics (APLM)	United States	$0.020B	0.00
Allarity Therapeutics (ALLR)	United States	$0.019B	0.00
Cadrenal Therapeutics (CVKD)	United States	$0.017B	0.00
Polyrizon (PLRZ)	Israel	$0.017B	0.00
Bionano Genomics (BNGO)	United States	$0.016B	0.00
Hoth Therapeutics (HOTH)	United States	$0.016B	0.00
Applied Therapeutics (APLT)	United States	$0.016B	0.00
Cocrystal Pharma (COCP)	United States	$0.014B	0.00
BioCardia (BCDA)	United States	$0.014B	0.00
Soligenix (SNGX)	United States	$0.014B	0.00
Sensei Biotherapeutics (SNSE)	United States	$0.013B	0.00
Beyond Air (XAIR)	United States	$0.013B	0.00
Bolt Biotherapeutics (BOLT)	United States	$0.013B	0.00
Longeveron (LGVN)	United States	$0.012B	0.00
Novogen (KZIA)	Australia	$0.012B	0.00
NewcelX (NCEL)	Switzerland	$0.012B	0.00
Curis (CRIS)	United States	$0.012B	0.00
Edesa Biotech (EDSA)	Canada	$0.012B	0.00
IN8bio (INAB)	United States	$0.012B	0.00
Biofrontera (BFRI)	United States	$0.012B	0.00
Imunon (IMNN)	United States	$0.011B	0.00
Mainz Biomed (MYNZ)	Germany	$0.011B	0.00
Chemomab Therapeutics (CMMB)	Israel	$0.010B	0.00
Biorestorative Therapies (BRTX)	United States	$0.010B	0.00
Gelteq (GELS)	Australia	$0.010B	0.00
Akari Therapeutics (AKTX)	United Kingdom	$0.010B	0.00
Moleculin Biotech (MBRX)	United States	$0.010B	0.00
GENPREX (GNPX)	United States	$0.009B	0.00
Cuprina Holdings (Cayman) (CUPR)	Singapore	$0.009B	0.00
Purple Biotech (PPBT)	Israel	$0.009B	0.00
Aptevo Therapeutics (APVO)	United States	$0.008B	0.00
Alzamend Neuro (ALZN)	United States	$0.008B	0.00
BRIACELL THERAP (BCTX)	Canada	$0.008B	0.00
IMMURON (IMRN)	Australia	$0.008B	0.00
Mustang Bio (MBIO)	United States	$0.008B	0.00
GT Biopharma (GTBP)	United States	$0.008B	0.00
Abpro Holdings (ABP)	United States	$0.007B	0.00
Advanced Biomed (ADVB)	United States	$0.007B	0.00
Dogwood Therapeutics (DWTX)	United States	$0.007B	0.00
Silexion Therapeutics Corp (SLXN)	Israel	$0.007B	0.00
Acurx Pharmaceuticals (ACXP)	United States	$0.006B	0.00
Adial Pharmaceuticals (ADIL)	United States	$0.006B	0.00
MetaVia (MTVA)	United States	$0.006B	0.00
BioAffinity Technologies (BIAF)	United States	$0.006B	0.00
Cyclerion Therapeutics (CYCN)	United States	$0.006B	0.00
Sunshine Biopharma (SBFM)	United States	$0.006B	0.00
KALA BIO (KALA)	United States	$0.006B	0.00
Aprea Therapeutics (APRE)	United States	$0.006B	0.00
Evogene (EVGN)	Israel	$0.006B	0.00
Creative Medical Technology Holdings (CELZ)	United States	$0.005B	0.00
Aspire Biopharma Holdings (ASBP)	United States	$0.005B	0.00
Decoy Therapeutics Inc (DCOY)	United States	$0.005B	0.00
VivoSim Labs (VIVS)	United States	$0.005B	0.00
Silo Pharma (SILO)	United States	$0.005B	0.00
HCW Biologics (HCWB)	United States	$0.004B	0.00
AquaBounty Technologies (AQB)	United States	$0.004B	0.00
Revelation Biosciences (REVB)	United States	$0.004B	0.00
GeoVax Labs (GOVX)	United States	$0.004B	0.00
CNS Pharmaceuticals (CNSP)	United States	$0.004B	0.00
Propanc Biopharma Inc (PPCB)	Australia	$0.004B	0.00
Cardio Diagnostics Holdings (CDIO)	United States	$0.004B	0.00
Avalon GloboCare (ALBT)	United States	$0.004B	0.00
Artelo Biosciences (ARTL)	United States	$0.003B	0.00
Scinai Immunotherapeutics (SCNI)	Israel	$0.003B	0.00
Ensysce Biosciences (ENSC)	United States	$0.003B	0.00
Bone Biologics (BBLG)	United States	$0.003B	0.00
Arcadia Biosciences (RKDA)	United States	$0.003B	0.00
Enveric Biosciences (ENVB)	United States	$0.003B	0.00
Onconetix (ONCO)	United States	$0.002B	0.00
Dermata Therapeutics (DRMA)	United States	$0.002B	0.00
Psyence Biomedical (PBM)	Canada	$0.001B	0.00
Biodexa Pharmaceuticals (BDRX)	United Kingdom	$0.001B	0.00
Virax Biolabs Group (VRAX)	United Kingdom	$0.001B	0.00
GRI Bio (GRI)	United States	$0.001B	0.00
NuCana (NCNA)	United Kingdom	$0.000B	0.00
Aceragen (ACGN)	United States	$0.000B	0.00
ARAVIVE, INC (ARAV)	United States	$0.000B	0.00
Compugen (CGEN)	Israel	$0.000B	0.00
Cellectis S.A (CLLS)	France	$0.000B	0.00
Clovis Oncology (CLVSQ)	United States	$0.000B	0.00
Celyad SA (CYAD)	Belgium	$0.000B	0.00
CytoMed Therapeutics (GDTC)	Singapore	$0.000B	0.00
Galapagos (GLPG)	Belgium	$0.000B	0.00
Motif Bio Plc (MTFB)	United Kingdom	$0.000B	0.00
NeuroSense Therapeutics (NRSN)	Israel	$0.000B	0.00
PDL BioPharma (PDLI)	United States	$0.000B	0.00
Pharvaris (PHVS)	Netherlands	$0.000B	0.00
Pulmatrix (PULM)	United States	$0.000B	0.00
TFF Pharmaceuticals (TFFP)	United States	$0.000B	0.00
VectivBio Holding AG (VECT)	Switzerland	$0.000B	0.00